ECDC and EMCDDA make the case for active case finding of communicable diseases in prison
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
Understanding drug-resistant gonorrhoea: an ECDC whole genome sequencing study
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
Pre-exposure prophylaxis in the EU/EEA setting: challenges and opportunities
Although clinical trials and other studies have demonstrated the efficacy and effectiveness of pre-exposure prophylaxis (PrEP) for HIV and existing guidelines have recommended making PrEP available within combination HIV prevention packages, there is not yet clear consensus in Europe with regard to whether and how to implement PrEP.